4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Castle Biosciences, Inc. (CSTL) operates in the Diagnostics & Research industry and is headquartered in Friendswood, United States with about 942 employees. Its market capitalization is roughly $745 million. In the fiscal year ended 2025-12-31, CSTL reported $344M in revenue and ($24M) in net income.
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma.
Interactive charts & full statements → Open the CSTL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $344M | $332M | $220M | $137M | — |
| Gross Profit | $273M | $272M | $175M | $105M | — |
| Operating Income (EBIT) | ($43M) | $9M | ($68M) | ($91M) | — |
| Net Income | ($24M) | $18M | ($58M) | ($67M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $84M | $87M | $83M | $86M | $88M |
| Gross Profit | $63M | $69M | $64M | $69M | $72M |
| Operating Income (EBIT) | ($18M) | ($4M) | ($7M) | ($4M) | ($28M) |
| Net Income | ($14M) | ($2M) | ($0M) | $4M | ($26M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $579M | $531M | $453M | $447M | — |
| Total Liabilities | $108M | $75M | $62M | $48M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CSTL viewer.
About TickerBase · Data methodology & sources